ArticleJournal of Cancer2017

Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.

Marianna Scrima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.